We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Supreme Court Refuses Merck’s Appeal Over $200 Million Gilead Verdict
Supreme Court Refuses Merck’s Appeal Over $200 Million Gilead Verdict
The Supreme Court declined to consider Merck’s appeal of a California court ruling that overturned a $200 million jury award against Gilead over a hepatitis C drug patent.